Outcome of Obstructed Total Anamalous Pulmonary Venous Connection (TAPVC) Repair Patients with Milrinone Versus Milrinone and Inhaled Nitric Oxide (INO): A Prospective Randomized Observational Study
Annals of Cardiac Anaesthesia · 2023
DOI: 10.4103/aca.aca_56_22 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift Annals of Cardiac Anaesthesia, 2023. Verfasst von Srikanth Gujja und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiac Anesthesia, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India. Hauptthemen laut MEDLINE: Lung Diseases, Hypertension, Pulmonary. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 26 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
Obstructed total anomalous pulmonary venous connection (TAPVC) typically present with severe cardiovascular decompensation and requires urgent surgical management. Pulmonary arterial hypertension (PAH) is a major risk factor affecting mortality. Perioperative management focuses on providing inotropic support and managing potential pulmonary hypertensive episodes. Milrinone and inhaled nitric oxide (iNO) efficiently reduce pulmonary artery pressure (PAP) and help to improve the outcome. The aim was to determine the outcome of patients with high PAP with milrinone alone and a combination of iNO and milrinone. Material and Method: After ethical committee approval, the study was conducted over a period of 3 years in 80 patients with obstructed TAPVC repair. A total of 80 patients having severe PAH (supra systemic arterial pressure) randomly divided into two groups with 40 patients in each (M & MN). Group M (milrinone) patients received milrinone and Group MN (milrinone & iNO) patients received both milrinone (after opening aortic cross clamp) and iNO (post operative ICU). Ventilation time, hospital stay, ICU stay, complications, in hospital mortality were compared between both groups.
Result
Ventilation time, Intensive Care Unit (ICU) stay, hospital stay for group M was 8.02 ± 5.74 days, 11.25 ± 7.33 day, 14.92 ± 8.55 days, respectively, and for group MN was 5.02 ± 1.78 days, 8.27 ± 3.24 days, 10.3 ± 3.18 days, respectively. In hospital mortality for group M and MN was 10% and 2.5%, respectively. P value for each variable was significant < 0.05 (except mortality).
Conclusion
Most of the patients with obstructed TAPVC had severe PAH. Management of severe PAH with a combination of milrinone with iNO had a better outcome than milrinone alone.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Cardiac Anesthesia, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India.
- Research, U. N. Mehta Institute of Cardiology and Research Centre, Ahmedabad, Gujarat, India.
Zitieren
APA
Gujja, S., Prajapati, M., Chuada, T. R., Gandhi, H., Arora, V., Kaul, V., & Patel, S. (2023). Outcome of Obstructed Total Anamalous Pulmonary Venous Connection (TAPVC) Repair Patients with Milrinone Versus Milrinone and Inhaled Nitric Oxide (INO): A Prospective Randomized Observational Study. Annals of Cardiac Anaesthesia. https://doi.org/10.4103/aca.aca_56_22
Vancouver
Gujja S, Prajapati M, Chuada TR, Gandhi H, Arora V, Kaul V, et al. Outcome of Obstructed Total Anamalous Pulmonary Venous Connection (TAPVC) Repair Patients with Milrinone Versus Milrinone and Inhaled Nitric Oxide (INO): A Prospective Randomized Observational Study. Annals of Cardiac Anaesthesia. 2023. doi:10.4103/aca.aca_56_22
BibTeX
@article{Gujja2023,
author = {Gujja, Srikanth and Prajapati, Mrugesh and Chuada, Tanya R and Gandhi, Hemang and Arora, Varun and Kaul, Vivek and Patel, Sanjay},
title = {Outcome of Obstructed Total Anamalous Pulmonary Venous Connection (TAPVC) Repair Patients with Milrinone Versus Milrinone and Inhaled Nitric Oxide (INO): A Prospective Randomized Observational Study},
journal = {Annals of Cardiac Anaesthesia},
year = {2023},
doi = {10.4103/aca.aca_56_22}
}
EUVIMED